Pitcairn Co. Purchases 963 Shares of Molina Healthcare, Inc. (NYSE:MOH)

Pitcairn Co. grew its stake in shares of Molina Healthcare, Inc. (NYSE:MOH) by 111.3% during the 1st quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,828 shares of the company’s stock after acquiring an additional 963 shares during the quarter. Pitcairn Co.’s holdings in Molina Healthcare were worth $751,000 as of its most recent SEC filing.

Several other hedge funds have also recently modified their holdings of MOH. McIlrath & Eck LLC purchased a new stake in Molina Healthcare in the fourth quarter valued at approximately $34,000. Principal Securities Inc. purchased a new stake in Molina Healthcare in the fourth quarter valued at approximately $42,000. Householder Group Estate & Retirement Specialist LLC boosted its position in Molina Healthcare by 3,933.3% in the fourth quarter. Householder Group Estate & Retirement Specialist LLC now owns 121 shares of the company’s stock valued at $43,000 after buying an additional 118 shares during the last quarter. Friedenthal Financial purchased a new stake in Molina Healthcare in the fourth quarter valued at approximately $43,000. Finally, Allworth Financial LP boosted its position in Molina Healthcare by 80.0% in the fourth quarter. Allworth Financial LP now owns 135 shares of the company’s stock valued at $49,000 after buying an additional 60 shares during the last quarter. Institutional investors and hedge funds own 98.50% of the company’s stock.

Molina Healthcare Stock Up 12.3 %

Shares of MOH traded up $35.45 during midday trading on Thursday, hitting $324.17. The company had a trading volume of 2,888,871 shares, compared to its average volume of 479,260. The company’s 50-day simple moving average is $307.61 and its 200-day simple moving average is $353.85. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49. The firm has a market capitalization of $19.00 billion, a P/E ratio of 17.60, a P/E/G ratio of 0.88 and a beta of 0.58. Molina Healthcare, Inc. has a 1 year low of $282.96 and a 1 year high of $423.92.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings data on Wednesday, July 24th. The company reported $5.86 earnings per share (EPS) for the quarter, beating the consensus estimate of $5.73 by $0.13. Molina Healthcare had a return on equity of 29.86% and a net margin of 2.99%. The business had revenue of $9.88 billion during the quarter, compared to analysts’ expectations of $9.75 billion. During the same quarter last year, the business posted $5.65 EPS. The business’s quarterly revenue was up 18.7% compared to the same quarter last year. As a group, sell-side analysts expect that Molina Healthcare, Inc. will post 23.56 EPS for the current year.

Insider Transactions at Molina Healthcare

In other news, Director Ronna Romney sold 250 shares of the firm’s stock in a transaction dated Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the sale, the director now owns 16,945 shares of the company’s stock, valued at approximately $5,816,710.15. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other Molina Healthcare news, Director Ronna Romney sold 250 shares of Molina Healthcare stock in a transaction that occurred on Tuesday, May 21st. The stock was sold at an average price of $343.27, for a total transaction of $85,817.50. Following the transaction, the director now owns 16,945 shares of the company’s stock, valued at $5,816,710.15. The transaction was disclosed in a filing with the SEC, which is available at this link. Also, COO James Woys sold 10,000 shares of Molina Healthcare stock in a transaction that occurred on Wednesday, May 22nd. The stock was sold at an average price of $345.15, for a total value of $3,451,500.00. Following the transaction, the chief operating officer now directly owns 53,613 shares in the company, valued at approximately $18,504,526.95. The disclosure for this sale can be found here. Corporate insiders own 1.10% of the company’s stock.

Analysts Set New Price Targets

MOH has been the topic of several recent research reports. JPMorgan Chase & Co. lowered their price objective on Molina Healthcare from $420.00 to $395.00 and set an “overweight” rating on the stock in a research report on Wednesday, July 10th. Bank of America lowered Molina Healthcare from a “neutral” rating to an “underperform” rating and set a $439.00 target price on the stock. in a research report on Thursday, March 28th. Barclays reduced their price objective on Molina Healthcare from $437.00 to $430.00 and set an “equal weight” rating for the company in a research note on Thursday, April 25th. Wells Fargo & Company cut their target price on Molina Healthcare from $375.00 to $315.00 and set an “equal weight” rating for the company in a research note on Monday. Finally, Jefferies Financial Group cut their target price on Molina Healthcare from $354.00 to $297.00 and set a “hold” rating for the company in a research note on Wednesday. One analyst has rated the stock with a sell rating, five have issued a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $376.18.

Molina Healthcare Company Profile

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.